Drug safety in porphyria

Perampanel for focal epilepsy: insights from early clinical experience.

Acta neurologica Scandinavica·2015

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

Acta neurologica Scandinavica. Supplementum·2012

Patterns of treatment response in newly diagnosed epilepsy.

Neurology·2012

Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit.

Acta neurologica Scandinavica·2011

Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions.

Biochemical pharmacology·2010

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.

Neurology·2010

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Methodological considerations for designing and conducting open-label placebo trials.

Pain·2026

Efficacy of intravenous ketamine for neuropathic pain: a systematic review and meta-analysis of randomized clinical trials.

Pain management·2026

Data-driven in silico toxicity profiling of marketed drugs and retrospective analysis of post-marketing withdrawal risk.

Toxicology mechanisms and methods·2026

Influence of sex, anxiety, and risk-taking behavior on opioid and alcohol polysubstance consumption patterns.

Addiction neuroscience·2026

Assessing the Safety of Medications During Lactation: Lactation safety.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026

Related Experiment Videos

Drug safety in porphyria

Related Concept Videos

Perampanel for focal epilepsy: insights from early clinical experience.

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

Patterns of treatment response in newly diagnosed epilepsy.

Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit.

Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions.

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Methodological considerations for designing and conducting open-label placebo trials.

Efficacy of intravenous ketamine for neuropathic pain: a systematic review and meta-analysis of randomized clinical trials.

Data-driven in silico toxicity profiling of marketed drugs and retrospective analysis of post-marketing withdrawal risk.

Influence of sex, anxiety, and risk-taking behavior on opioid and alcohol polysubstance consumption patterns.

Assessing the Safety of Medications During Lactation: Lactation safety.

Related Experiment Videos

Drug safety in porphyria

Related Concept Videos

Related Articles